![](https://investorshub.advfn.com/uicon/108232.png?cb=1511469001)
Wednesday, May 29, 2013 3:31:36 PM
The study, “Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs” suggests that Hemispherx’ s lead drug, Alferon N Injection, tested among 19 clinically approved compounds from several major antiviral pharmacologic classes, exhibits the most potent antiviral activity in an in-vitro model of SARS-CoV infection and is a potential drug for in vivo research.
Today's Headline News 3 Hrs Ago:
http://news.yahoo.com/blogs/lookout/virus-called-threat-entire-world-152046513.html
The Centers for Disease Control explains that coronaviruses can affect people or animals and, in worst-case scenarios, cause SARS (severe acute respiratory syndrome). And it notes there's currently no vaccine to protect against human coronavirus infection
DONT LISTEN TO ME IM CANADIANNNNNNNN
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM